Showing results (191-200 of 871) with videos related to
Sort By:
Pageof 88
Biochemical Pharmacology|April 1, 1982
Inhibition of rat liver monoamine oxidase by alpha-methyl- and N-propargyl-amine derivativesK F Tipton, J M McCrodden, A S Kalir, et al.Journal of Neurochemistry|August 25, 2001
Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinolW Maruyama, Y Akao, M B Youdim, et al.Journal of Neurochemistry|August 1, 1995
Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigraM Gerlach, A X Trautwein, L Zecca, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Brain iron and ferritin in Parkinson's and Alzheimer's diseasesK Jellinger, W Paulus, I Grundke-Iqbal, et al.Biochemical Pharmacology|February 11, 1994
The interactions of milacemide with monoamine oxidaseE M O'Brien, K F Tipton, J M McCrodden, et al.Hormone Research|January 1, 1992
Growth-hormone-binding protein in patients with acromegalyT Amit, S Ish-Shalom, B Glaser, et al.Journal of Neurochemistry|April 1, 1988
Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase BP Janssens de Varebeke, R Cavalier, M David-Remacle, et al.Journal of Neural Transmission|January 1, 1978
Central and peripheral catecholamines and phenylethanolamine-N-methyl-transferase activity during the oestrus cycleS Parvez, G Ismahan, A Raza-Bukhari, et al.European Journal of Pharmacology|October 22, 1985
Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-BR E Heikkila, R C Duvoisin, J P Finberg, et al.Brain Research|September 3, 1986
Serotonin metabolism and the nature of monoamine oxidase in squid central nervous systemM B Youdim, S C Feldman, G D Pappas, et al.Pageof 88